| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/20/2009 | CN101437525A Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 05/20/2009 | CN101437504A Metal-containing virucidal compositions and uses |
| 05/20/2009 | CN101434956A Heavy and light chain variable region gene of monoclonal antibody, encoding polypeptide thereof and use |
| 05/20/2009 | CN101434955A Recombinant expression method of insect C-type lectin and use |
| 05/20/2009 | CN101434928A Recombinant bacteria expressing avian Escherichia coli type 1 pilin, and construction method and use thereof |
| 05/20/2009 | CN101434650A Bursa pentapeptide, deriving peptide thereof and use thereof |
| 05/20/2009 | CN101434627A 2'-fluoro-4'-substituted nucleoside analogue, synthetic method and use thereof |
| 05/20/2009 | CN101434611A Nitrogen heterocyclic ring substituted antibiotic, and preparation method and use thereof |
| 05/20/2009 | CN101434601A 2-furyl-1H-benzimidazole-4-acidamide type derivative |
| 05/20/2009 | CN101434595A Antifungal agent-sulfur chromanone thiosemicarbazone compounds |
| 05/20/2009 | CN101434593A Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/20/2009 | CN101434584A Chiral oxazolidinone compound with antibacterial activity |
| 05/20/2009 | CN101434570A Pyrrolidine derivative, and preparation and use thereof |
| 05/20/2009 | CN101434560A Alkyloxycarbonyl substituted abricycline derivative |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433703A Medicinal granules for treating common cold and formulating method thereof |
| 05/20/2009 | CN101433702A Health-care wine for preventing avian influenza and formulating method thereof |
| 05/20/2009 | CN101433691A Zedoary turmeric oil extract as well as preparation method and application thereof |
| 05/20/2009 | CN101433686A Chinese medicine for clearing viscera |
| 05/20/2009 | CN101433685A Medicament for treating icteric hepatitis and preparation method thereof |
| 05/20/2009 | CN101433684A Medicine for curing hepatitis B and preparation method thereof |
| 05/20/2009 | CN101433682A Medicine for treating pulmonary tuberculosis and preparation method thereof |
| 05/20/2009 | CN101433681A Pure Chinese medicine for resisting tuberculosis |
| 05/20/2009 | CN101433673A Cold treating medicine |
| 05/20/2009 | CN101433671A Medicine for treating syphilis |
| 05/20/2009 | CN101433662A Prescription containing double formulas for quickly treating scrofula and processing |
| 05/20/2009 | CN101433658A Composition for preventing and treating chicken pox |
| 05/20/2009 | CN101433644A Plaster for treating children's lymph node |
| 05/20/2009 | CN101433621A Chinese medicinal composition for treating asthma of pig as well as preparation method and use thereof |
| 05/20/2009 | CN101433619A Tinctura for eliminating tinea and relieving itching |
| 05/20/2009 | CN101433596A Extract containing astragalus with efficacy for protecting liver and expelling toxin |
| 05/20/2009 | CN101433594A Sugar-free honeysuckle flower common cold granule |
| 05/20/2009 | CN101433579A Antivirus transdermal emulsifiable paste containing penciclovir, liquorice, astragalus, cassia nomame and basil |
| 05/20/2009 | CN101433566A Injection |
| 05/20/2009 | CN101433551A Use of mercuride in preparing antiviral medicament |
| 05/20/2009 | CN101433548A Use of arsenide in preparing antiviral medicament |
| 05/20/2009 | CN101433543A Compound mequindox injection |
| 05/20/2009 | CN101433537A External-use spray for resisting mycotic infection of superficial part and preparation method thereof |
| 05/20/2009 | CN101433532A Novel use of Chinese medicine component |
| 05/20/2009 | CN101433529A Glycyrrhizic acid transdermal formulation and preparation technique thereof |
| 05/20/2009 | CN101433522A Method for preparing andrographolide solid dispersion |
| 05/20/2009 | CN101433519A Azithromycin eye drops and preparation method thereof |
| 05/20/2009 | CN101433518A Compound ofloxacin injection for animals |
| 05/20/2009 | CN101433517A Compound oxytetracycline injection |
| 05/20/2009 | CN100489107C DNA transfection system for the generation of infectious influenza virus |
| 05/20/2009 | CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector |
| 05/20/2009 | CN100489092C Type II genetic marker strain of porcine circovirus and its application |
| 05/20/2009 | CN100488979C Glycyrrhetinic acid-30-acylamide derivatives and its use |
| 05/20/2009 | CN100488973C High efficiency extracting method for sophora alopecuroide total alkaloid |
| 05/20/2009 | CN100488970C Crystal form of adefovir dipivoxil |
| 05/20/2009 | CN100488965C Water soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 05/20/2009 | CN100488950C Use of chemotherapeutic agents |
| 05/20/2009 | CN100488946C Salts of guanidine derivatives and its pharmaceutical preparations composition |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/20/2009 | CN100488561C Method for preparing interferon long-acting injection microsphere preparation |
| 05/20/2009 | CN100488547C Pharmaceutical composition for treating tinea and complication thereof |
| 05/20/2009 | CN100488543C Local externally applied itch stopping garlic liniments |
| 05/20/2009 | CN100488527C Menyanthes root extraction and its preparation method and usage |
| 05/20/2009 | CN100488517C Composition for trapping and inactivating pathogenic microbes and spermatozoa and its pharmaceutical uses |
| 05/20/2009 | CN100488515C Ground erythromycin enteric micropill and its preparation method |
| 05/20/2009 | CN100488508C Pharmaceutical composition containing tetrahydroisoquinoline compounds |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488501C Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyper-permeability or undesired permeability |
| 05/20/2009 | CN100488500C Use of COX-2 inhibitors for preventing immunodeficiency |
| 05/19/2009 | US7534871 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534782 3-(2-Guanidinoacetylamino)pyrrolidin-1-ylcarbonyl]-1-methylpyrrolidin-4-ylthio]-6-[(1R)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylic acid ethanolate; viricide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Pseudomonas aeruginosa; storage stability |
| 05/19/2009 | US7534559 Feline polynucleotide vaccine formula |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2400784C Therapeutic product, use and formulation thereof |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2386685C Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 05/19/2009 | CA2379435C Topical azathioprine for the treatment of oral autoimmune diseases |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/19/2009 | CA2210891C Valaciclovir tablets containing colloidal silicon dioxide |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/19/2009 | CA2118509C Attenuated respiratory syncytial virus vaccine compositions |
| 05/15/2009 | CA2625152A1 Zeolite supported metallic nanodots |
| 05/14/2009 | WO2009061889A2 Grape polyphenolics for platelet and bacterial control |
| 05/14/2009 | WO2009061770A2 Method of inhibiting abcg2 and related treatments |
| 05/14/2009 | WO2009060961A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
| 05/14/2009 | WO2009060493A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field |
| 05/14/2009 | WO2009060445A1 Synthetic sphingolipid analogs |
| 05/14/2009 | WO2009060316A2 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 05/14/2009 | WO2009060122A2 Use of oligonucleotides with modified bases as antiviral agents |
| 05/14/2009 | WO2009059996A1 Prevention and treatment of secondary infections following viral infection |
| 05/14/2009 | WO2009059452A1 Tetriacyclodipyranyl coumarins and the anti-hiv and anti-tuberculosis uses thereof |
| 05/14/2009 | WO2009059388A1 Use of antagonists of platelet receptor factor for the treatment of infections caused by the influenza virus |
| 05/14/2009 | WO2009059350A1 Anti-microbial polymers and their compositions |
| 05/14/2009 | WO2009040083A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040047A3 Therapeutic uses of ghrelin and combinations with stresscopin |
| 05/14/2009 | WO2009040033A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040019A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009039986A3 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent |